Literature DB >> 23676757

Identification of biomarkers for Mycobacterium tuberculosis infection and disease in BCG-vaccinated young children in Southern India.

S Dhanasekaran1, S Jenum, R Stavrum, C Ritz, D Faurholt-Jepsen, J Kenneth, M Vaz, H M S Grewal, T M Doherty.   

Abstract

Pediatric tuberculosis (TB) often goes undiagnosed because of the lack of reliable diagnostic methods. With the aim of assessing biomarker(s) that can aid in the diagnosis of TB infection and disease, we investigated 746 Indian children with suspected TB. Whole-blood mRNA from 210 children was examined by dual-color Reverse-Transcriptase Multiple Ligation-dependent Probe-Amplification for the expression of 45 genes and a Bio-Plex assay for the expression of cytokines/chemokines in QuantiFERON supernatants. The study shows that transcription of SEC14L1, GUSB, BPI, CCR7 and TGFβ-1 (all P ≤ 0.05) was downregulated in TB disease compared with uninfected controls, while transcription of RAB33A was downregulated in TB disease compared with both latent TB (P < 0.05) and controls (P < 0.01). The transcription of CD4, TGFβ-1 (P < 0.01) and the expression of IL-2 (P < 0.01) and IL-13 (P < 0.05) was upregulated in latent TB compared with that in controls. Using the Least Absolute Shrinkage and Selection Operator (lasso) model, RAB33A alone discriminated between TB disease and latent TB (area under the curve (AUC) 77.5%), whereas a combination of RAB33A, CXCL10, SEC14L1, FOXP3 and TNFRSF1A was effective in discriminating between TB disease and controls (AUC 91.7%). A combination of 11 biomarkers predicted latent TB with moderate discriminatory power (AUC 72.2%). In conclusion, RAB33A is a potential biomarker for TB disease, whereas CD4, TGFβ-1 and IL-2, IL-13 may identify latent TB in children.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23676757     DOI: 10.1038/gene.2013.26

Source DB:  PubMed          Journal:  Genes Immun        ISSN: 1466-4879            Impact factor:   2.676


  20 in total

1.  Alternative Quantiferon cytokines for diagnosis of children with active tuberculosis and HIV co-infection in Ghana.

Authors:  Christian Lundtoft; Anthony Afum-Adjei Awuah; Norman Nausch; Anthony Enimil; Ertan Mayatepek; Ellis Owusu-Dabo; Marc Jacobsen
Journal:  Med Microbiol Immunol       Date:  2017-03-15       Impact factor: 3.402

Review 2.  Cytokines and Chemokines in Mycobacterium tuberculosis Infection.

Authors:  Racquel Domingo-Gonzalez; Oliver Prince; Andrea Cooper; Shabaana A Khader
Journal:  Microbiol Spectr       Date:  2016-10

3.  Concordant or discordant results by the tuberculin skin test and the quantiFERON-TB test in children reflect immune biomarker profiles.

Authors:  S Dhanasekaran; S Jenum; R Stavrum; C Ritz; J Kenneth; M Vaz; T M Doherty; H M S Grewal
Journal:  Genes Immun       Date:  2014-04-17       Impact factor: 2.676

4.  Lesion-Specific Immune Response in Granulomas of Patients with Pulmonary Tuberculosis: A Pilot Study.

Authors:  Selvakumar Subbian; Liana Tsenova; Mi-Jeong Kim; Helen C Wainwright; Annalie Visser; Nirmalya Bandyopadhyay; Joel S Bader; Petros C Karakousis; Gabriele B Murrmann; Linda-Gail Bekker; David G Russell; Gilla Kaplan
Journal:  PLoS One       Date:  2015-07-02       Impact factor: 3.240

5.  Effect of non-tuberculous Mycobacteria on host biomarkers potentially relevant for tuberculosis management.

Authors:  S Dhanasekaran; Synne Jenum; Ruth Stavrum; Harald G Wiker; John Kenneth; Mario Vaz; T Mark Doherty; Harleen M S Grewal
Journal:  PLoS Negl Trop Dis       Date:  2014-10-16

6.  Approaching a diagnostic point-of-care test for pediatric tuberculosis through evaluation of immune biomarkers across the clinical disease spectrum.

Authors:  Synne Jenum; S Dhanasekaran; Rakesh Lodha; Aparna Mukherjee; Deepak Kumar Saini; Sarman Singh; Varinder Singh; Guruprasad Medigeshi; Marielle C Haks; Tom H M Ottenhoff; Timothy Mark Doherty; Sushil K Kabra; Christian Ritz; Harleen M S Grewal
Journal:  Sci Rep       Date:  2016-01-04       Impact factor: 4.379

7.  Lipoarabinomannan Decreases Galectin-9 Expression and Tumor Necrosis Factor Pathway in Macrophages Favoring Mycobacterium tuberculosis Intracellular Growth.

Authors:  Leslie Chávez-Galán; Lucero Ramon-Luing; Claudia Carranza; Irene Garcia; Isabel Sada-Ovalle
Journal:  Front Immunol       Date:  2017-11-27       Impact factor: 7.561

8.  Analysis of Plasma Cytokine and Chemokine Profiles in Patients with and without Tuberculosis by Liquid Array-Based Multiplexed Immunoassays.

Authors:  Wenjing Xiong; Haiping Dong; Juanjuan Wang; Xiaoming Zou; Qian Wen; Wei Luo; Sudong Liu; Jianchun He; Shaoxi Cai; Li Ma
Journal:  PLoS One       Date:  2016-02-16       Impact factor: 3.240

9.  BLR1 and FCGR1A transcripts in peripheral blood associate with the extent of intrathoracic tuberculosis in children and predict treatment outcome.

Authors:  Synne Jenum; Rasmus Bakken; S Dhanasekaran; Aparna Mukherjee; Rakesh Lodha; Sarman Singh; Varinder Singh; Marielle C Haks; Tom H M Ottenhoff; S K Kabra; T Mark Doherty; Christian Ritz; Harleen M S Grewal
Journal:  Sci Rep       Date:  2016-12-12       Impact factor: 4.379

10.  Novel transcriptional signatures for sputum-independent diagnostics of tuberculosis in children.

Authors:  John Espen Gjøen; Synne Jenum; Dhanasekaran Sivakumaran; Aparna Mukherjee; Ragini Macaden; Sushil K Kabra; Rakesh Lodha; Tom H M Ottenhoff; Marielle C Haks; Timothy Mark Doherty; Christian Ritz; Harleen M S Grewal
Journal:  Sci Rep       Date:  2017-07-19       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.